GARP Research Maintains a 'Buy' on Luminex (LMNX); Q1 Review
Tweet
Share
E-mailGet Alerts LMNX Hot Sheet
Price: $8.99 +10.44%
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
GARP Research maintains a 'Buy' on Luminex (NASDAQ: LMNX).
Analyst, Alastair Mackay, said, "Revenue growth of 12% was propelled by assays from EraGen, acquired last year. The organic rate of ~2% was crimped by a tough comparable on consumable sales. EraGen’s high SG&A pushed earnings down. Meanwhile, partner Bio-Rad signed on as a MagPix distributor."
"GARP projects that xMAP will become one of the most widely used platforms in
multiplexed molecular diagnostics. Revenue from this rapidly-expanding sector may exceed $90 million by 2014, becoming Luminex’s primary growth driver. The installed base of instruments increased by 1,000 in 2011; there are now 8,900 in service. Competitors are years behind."
For an analyst ratings summary and ratings history on Luminex click here. For more ratings news on Luminex click here.
Shares of Luminex closed at $24.86 yesterday.
Analyst, Alastair Mackay, said, "Revenue growth of 12% was propelled by assays from EraGen, acquired last year. The organic rate of ~2% was crimped by a tough comparable on consumable sales. EraGen’s high SG&A pushed earnings down. Meanwhile, partner Bio-Rad signed on as a MagPix distributor."
"GARP projects that xMAP will become one of the most widely used platforms in
multiplexed molecular diagnostics. Revenue from this rapidly-expanding sector may exceed $90 million by 2014, becoming Luminex’s primary growth driver. The installed base of instruments increased by 1,000 in 2011; there are now 8,900 in service. Competitors are years behind."
For an analyst ratings summary and ratings history on Luminex click here. For more ratings news on Luminex click here.
Shares of Luminex closed at $24.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
